Cargando…
MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
PURPOSE: To explore the profiles of immune and stromal components of the tumor microenvironment (TME) and their related key genes in gliomas. METHODS: We applied bioinformatic techniques to identify the core gene that participated in the regulation of the TME of the gliomas. And immunohistochemistry...
Autores principales: | Guo, Qinglong, Xiao, Xing, Zhang, Jinsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059377/ https://www.ncbi.nlm.nih.gov/pubmed/33898320 http://dx.doi.org/10.3389/fonc.2021.654388 |
Ejemplares similares
-
Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment
por: Wang, Zhihao, et al.
Publicado: (2022) -
Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020) -
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020) -
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020) -
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)